Adherex Technologies (FENC) Competitors $8.76 -0.27 (-2.99%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$8.79 +0.03 (+0.34%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FENC vs. SPRY, PRAX, QURE, ATAI, CRON, CRMD, TSHA, IMNM, AMLX, and IOVAShould you be buying Adherex Technologies stock or one of its competitors? The main competitors of Adherex Technologies include ARS Pharmaceuticals (SPRY), Praxis Precision Medicines (PRAX), uniQure (QURE), atai Life Sciences (ATAI), Cronos Group (CRON), CorMedix (CRMD), Taysha Gene Therapies (TSHA), Immunome (IMNM), Amylyx Pharmaceuticals (AMLX), and Iovance Biotherapeutics (IOVA). These companies are all part of the "pharmaceutical products" industry. Adherex Technologies vs. Its Competitors ARS Pharmaceuticals Praxis Precision Medicines uniQure atai Life Sciences Cronos Group CorMedix Taysha Gene Therapies Immunome Amylyx Pharmaceuticals Iovance Biotherapeutics Adherex Technologies (NASDAQ:FENC) and ARS Pharmaceuticals (NASDAQ:SPRY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends. Do analysts prefer FENC or SPRY? Adherex Technologies presently has a consensus price target of $13.33, suggesting a potential upside of 52.21%. ARS Pharmaceuticals has a consensus price target of $32.50, suggesting a potential upside of 224.03%. Given ARS Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe ARS Pharmaceuticals is more favorable than Adherex Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adherex Technologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00ARS Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Is FENC or SPRY more profitable? Adherex Technologies has a net margin of -35.05% compared to ARS Pharmaceuticals' net margin of -42.74%. Adherex Technologies' return on equity of 0.00% beat ARS Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Adherex Technologies-35.05% N/A -23.92% ARS Pharmaceuticals -42.74%-21.85%-15.88% Does the media refer more to FENC or SPRY? In the previous week, ARS Pharmaceuticals had 12 more articles in the media than Adherex Technologies. MarketBeat recorded 13 mentions for ARS Pharmaceuticals and 1 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 1.62 beat ARS Pharmaceuticals' score of 0.63 indicating that Adherex Technologies is being referred to more favorably in the media. Company Overall Sentiment Adherex Technologies Very Positive ARS Pharmaceuticals Positive Which has more volatility and risk, FENC or SPRY? Adherex Technologies has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, ARS Pharmaceuticals has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Which has stronger valuation & earnings, FENC or SPRY? ARS Pharmaceuticals has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than ARS Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdherex Technologies$47.54M5.14-$440K-$0.42-20.86ARS Pharmaceuticals$112.34M8.82$8M-$0.49-20.47 Do institutionals & insiders hold more shares of FENC or SPRY? 55.5% of Adherex Technologies shares are held by institutional investors. Comparatively, 68.2% of ARS Pharmaceuticals shares are held by institutional investors. 11.0% of Adherex Technologies shares are held by company insiders. Comparatively, 33.5% of ARS Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryARS Pharmaceuticals beats Adherex Technologies on 12 of the 16 factors compared between the two stocks. Get Adherex Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FENC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FENC vs. The Competition Export to ExcelMetricAdherex TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$244.50M$3.15B$5.79B$10.19BDividend YieldN/A2.32%5.73%4.60%P/E Ratio-20.8621.4375.4026.02Price / Sales5.14419.38514.85113.09Price / Cash271.2444.4425.8129.91Price / Book-41.719.6112.166.25Net Income-$440K-$53.29M$3.29B$270.76M7 Day Performance-2.67%0.13%0.74%3.87%1 Month Performance2.70%5.55%5.00%5.49%1 Year Performance60.15%10.44%62.55%25.86% Adherex Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FENCAdherex Technologies2.4821 of 5 stars$8.76-3.0%$13.33+52.2%+60.1%$244.50M$47.54M-20.8610Positive NewsSPRYARS Pharmaceuticals2.5947 of 5 stars$10.70+6.3%$32.50+203.7%-24.6%$995.18M$89.15M-21.8490Positive NewsPRAXPraxis Precision Medicines2.2882 of 5 stars$40.75-13.0%$85.88+110.7%-37.0%$985.99M$8.55M-3.32110High Trading VolumeQUREuniQure3.2062 of 5 stars$17.43-2.9%$37.45+114.9%+191.3%$984.86M$27.12M-4.45500ATAIatai Life Sciences2.8766 of 5 stars$4.52-1.1%$11.25+148.9%+256.2%$979.53M$2.31M-6.5580Positive NewsCRONCronos Group2.4766 of 5 stars$2.48-0.8%N/A+16.1%$957.23M$117.61M49.60450CRMDCorMedix3.9063 of 5 stars$12.75+2.8%$17.33+35.9%+86.2%$925.65M$43.47M17.0030Trending NewsAnalyst ForecastInsider TradeShort Interest ↑TSHATaysha Gene Therapies2.2928 of 5 stars$3.24-3.6%$8.29+155.7%+34.1%$916.59M$8.33M-9.53180News CoverageInsider TradeIMNMImmunome2.3309 of 5 stars$9.40-10.6%$22.89+143.5%-42.3%$915.71M$9.04M-3.0540Positive NewsAMLXAmylyx Pharmaceuticals1.782 of 5 stars$10.44+2.4%$12.25+17.3%+344.7%$909.51M$87.37M-4.18200Positive NewsIOVAIovance Biotherapeutics4.4319 of 5 stars$2.38-4.4%$11.90+400.0%-78.0%$901.02M$164.07M-1.93500Positive News Related Companies and Tools Related Companies ARS Pharmaceuticals Alternatives Praxis Precision Medicines Alternatives uniQure Alternatives atai Life Sciences Alternatives Cronos Group Alternatives CorMedix Alternatives Taysha Gene Therapies Alternatives Immunome Alternatives Amylyx Pharmaceuticals Alternatives Iovance Biotherapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FENC) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FENC Stock Alerts